Resumen

ARRUTI, N. et al. Use of ocular drugs in pregnancy. Anales Sis San Navarra [online]. 2013, vol.36, n.3, pp.479-487. ISSN 1137-6627.  https://dx.doi.org/10.4321/S1137-66272013000300013.

The information available on the safety of medicines in pregnant women is limited and must be suitably channeled. Medication that is applied topically or as eye drops can present relevant systemic absorption and cross the placenta barrier or enter maternal milk. We have reviewed ophthalmic medicines according to the fetal risk categories proposed by the classification of the Food and Drug Administration (FDA). We evaluate the medicines of choice in the most frequent ophthalmic pathologies, as well as the medicines that must be avoided.

Palabras clave : Ophthalmic drugs; Pregnancy; Fetal risk.

        · resumen en Español     · texto en Español     · Español ( pdf )